Remove Communication Remove Compounding Remove Drug Development Remove Immunity
article thumbnail

Empress Therapeutics emerges with $50m to fund small molecule development

Pharmaceutical Technology

Life sciences venture capital firm Flagship Pioneering has unveiled Empress Therapeutics, a small molecule drug development startup. This will support development of its proprietary Chemilogics platform and drug discovery pipeline. So far, Empress claims to have generated 15 drug leads across multiple indications.